EME vs. ADMA
EME (EMCOR Group, Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. EME operates in Engineering & Construction (Industrials), while ADMA operates in Biotechnology (Healthcare). Over the past 10 years, EME returned 33.38%/yr vs 1.08%/yr for ADMA. At a 0.18 correlation, their price movements are largely independent.
Performance
EME vs. ADMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EME achieves a 34.80% return, which is significantly higher than ADMA's -55.81% return. Over the past 10 years, EME has outperformed ADMA with an annualized return of 33.38%, while ADMA has yielded a comparatively lower 1.08% annualized return.
EME
- 1D
- 0.78%
- 1M
- -10.62%
- YTD
- 34.80%
- 6M
- 31.07%
- 1Y
- 68.85%
- 3Y*
- 68.15%
- 5Y*
- 45.66%
- 10Y*
- 33.38%
ADMA
- 1D
- 1.13%
- 1M
- -1.35%
- YTD
- -55.81%
- 6M
- -58.43%
- 1Y
- -60.89%
- 3Y*
- 28.26%
- 5Y*
- 34.37%
- 10Y*
- 1.08%
EME vs. ADMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EME EMCOR Group, Inc. | 34.80% | 35.05% | 111.27% | 46.03% | 16.81% | 39.93% | 6.47% | 45.18% | -26.68% | 16.09% |
ADMA ADMA Biologics, Inc. | -55.81% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
Correlation
The correlation between EME and ADMA is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013 | 0.18 |
The correlation between EME and ADMA shifts across timeframes, from 0.18 (all time) to 0.30 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
EME:
$37.11B
ADMA:
$1.93B
EME:
$29.65
ADMA:
$0.68
EME:
27.79
ADMA:
11.91
EME:
2.09
ADMA:
3.86
EME:
9.60
ADMA:
4.95
EME:
$17.75B
ADMA:
$509.86M
EME:
$3.47B
ADMA:
$312.42M
EME:
$2.03B
ADMA:
$218.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EME vs. ADMA — Risk / Return Rank
EME
ADMA
EME vs. ADMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for EMCOR Group, Inc. (EME) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EME | ADMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.94 | ||
| Sortino ratioReturn per unit of downside risk | +4.00 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 0.77 | +0.56 |
| Calmar ratioReturn relative to maximum drawdown | 2.75 | -0.94 | +3.69 |
| Martin ratioReturn relative to average drawdown | 6.90 | -1.81 | +8.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EME | ADMA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.82 | -1.12 | +2.94 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.38 | 0.58 | +0.80 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 1.02 | 0.02 | +1.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.60 | -0.01 | +0.61 |
Drawdowns
EME vs. ADMA - Drawdown Comparison
The maximum EME drawdown since its inception was -70.56%, smaller than the maximum ADMA drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for EME and ADMA.
Loading charts...
Drawdown Indicators
| EME | ADMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.56% | -91.28% | +20.72% |
Max Drawdown (1Y)Largest decline over 1 year | -25.15% | -65.25% | +40.10% |
Max Drawdown (3Y)Largest decline over 3 years | -36.19% | -68.99% | +32.80% |
Max Drawdown (5Y)Largest decline over 5 years | -36.19% | -68.99% | +32.80% |
Max Drawdown (10Y)Largest decline over 10 years | -48.00% | -86.11% | +38.11% |
Current DrawdownCurrent decline from peak | -12.71% | -67.12% | +54.41% |
Average DrawdownAverage peak-to-trough decline | -15.36% | -53.05% | +37.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.02% | 33.62% | -23.60% |
Volatility
EME vs. ADMA - Volatility Comparison
The current volatility for EMCOR Group, Inc. (EME) is 7.08%, while ADMA Biologics, Inc. (ADMA) has a volatility of 11.89%. This indicates that EME experiences smaller price fluctuations and is considered to be less risky than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EME | ADMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.08% | 11.89% | -4.81% |
Volatility (6M)Calculated over the trailing 6-month period | 25.46% | 45.36% | -19.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.11% | 54.73% | -16.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.30% | 59.46% | -26.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.97% | 69.05% | -36.08% |
Dividends
EME vs. ADMA - Dividend Comparison
EME's dividend yield for the trailing twelve months is around 0.16%, while ADMA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EME EMCOR Group, Inc. | 0.16% | 0.16% | 0.20% | 0.32% | 0.36% | 0.41% | 0.35% | 0.37% | 0.54% | 0.39% | 0.45% | 0.67% |
Financials
EME vs. ADMA - Financials Comparison
This section allows you to compare key financial metrics between EMCOR Group, Inc. and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EME vs. ADMA - Profitability Comparison
EME - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EMCOR Group, Inc. reported a gross profit of 863.95M and revenue of 4.63B. Therefore, the gross margin over that period was 18.7%.
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
EME - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EMCOR Group, Inc. reported an operating income of 403.85M and revenue of 4.63B, resulting in an operating margin of 8.7%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
EME - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EMCOR Group, Inc. reported a net income of 305.48M and revenue of 4.63B, resulting in a net margin of 6.6%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
Frequently Asked Questions
EME and ADMA have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ADMA has higher volatility (11.89%) compared to EME (7.08%). In terms of maximum drawdown, EME dropped -70.56% vs ADMA's -91.28%.
EME currently has the higher Sharpe Ratio (1.82 vs -1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EME and ADMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer